Vertex Pharmaceuticals Inc (VRTX34)
BOV
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -4.153 | 8.179 | 42.829 | 16.16 | 27.022 | 18.6 | 21.036 | 17.467 |
Return on Equity (%) | -9.215 | 15.588 | 64.744 | 22.372 | 36.713 | 24.933 | 27.669 | 22.674 |
Return on Invested Capital (%) | 0.915 | 16.276 | 70.614 | 22.61 | 36.227 | 26.807 | 30.349 | 24.27 |
Operating Margin (%) | 0.826 | 1.682 | 20.815 | 34.914 | 51.162 | 36.86 | 48.005 | 44.327 |
Net Profit Margin (%) | -6.583 | 10.587 | 68.805 | 28.27 | 43.696 | 30.921 | 37.198 | 36.177 |
Book Value Per Share | 4.041 | 7.751 | 17.184 | 18.082 | 28.03 | 34.179 | 47.551 | 60.515 |
Earnings Per Share | -0.451 | 1.04 | 8.218 | 4.544 | 10.434 | 9.204 | 12.925 | 13.856 |
Cash Per Share | 4.768 | 6.576 | 10.386 | 12.005 | 23.041 | 26.702 | 40.87 | 40.24 |
Working Capital Per Share | 4.184 | 7.272 | 10.671 | 13.468 | 24.071 | 29.152 | 40.826 | 41.123 |
Operating Profit Per Share | 6.255 | 8.991 | 10.623 | 14.371 | 21.466 | 26.717 | 31.346 | 34.305 |
EBIT Per Share | -0.271 | -0.062 | 2.352 | 5.386 | 11.993 | 10.729 | 16.468 | 16.806 |
EBITDA Per Share | -0.271 | -0.062 | 2.352 | 5.386 | 11.993 | 10.729 | 16.468 | 16.806 |
Free Cash Flow Per Share | -0.471 | 1.822 | 8.308 | 4.422 | 11.012 | 9.633 | 13.145 | 14.155 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 248,3M | 253,25M | 255,17M | 258,99M | 259,89M | 254,48M | 257,01M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 257,01M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 38.02 | N/A | N/A | N/A | 47.926 | N/A | N/A |
Net Profit Margin (%) | N/A | 29.468 | N/A | N/A | N/A | 40.868 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 159,56B |
Ratio cours/bénéfice | 29,64 |
Ratio prix/ventes | 10,67 |
Ratio prix/liquidités | 10,21 |
Ratio prix/valeur comptable | 6,02 |
Rendement de dividende | - |
Actions en circulation | 257,68M |
Volume moyen (1 semaine) | 3,44k |
Volume moyen (1 mois) | 596 |
Variation sur 52 semaines | 27,67% |
Plus haut sur 52 semaines | 748,45 |
Plus bas sur 52 semaines | 493,27 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales